retatrutide phase 3 triumph just delivered the first top-line results for a triple agonist in obesity — and the findings from TRIUMPH-4 are striking👇 Retatrutide Severe Obesity Trial Shows

Kipnis adds

Why Phase 2 was not enough A 17.5% weight reduction at 24 weeks in 338 participants is encouraging, but it does not answer the questions regulators ask before an NDA

The theoretical advantages of bypassing hepatic first-pass metabolism are negated if the compound cannot adequately penetrate the skin barrier in the first place

Remember: your dose may need adjustments, but your price won'tPlexusDx pricing remains flat whether you start low or move to higher therapeutic doses

The abdomen is typically the best starting site at higher body weights

If you skipped a workout on injection day, this is a good time for moderate exercise